Fund Holdings — Ally Bridge Group (NY) LLC

Total Portfolio Value
$100.66M
Total Bought
$53.48M
Total Sold
$18.28M
Net Transaction
+$35.20M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
COMPASS PATHWAYS PLC(CMPS)01,045,000+1,045,00005,7795.74%+5,779
TARSUS PHARMACEUTICALS INC(TARS)080,859+80,85905,6725.64%+5,672
PRAXIS PRECISION MEDICINES I(PRAX)19,88232,810+12,9285,86010,57110.50%+4,711
CYTOMX THERAPEUTICS INC.(CTMX)0900,000+900,00004,2304.20%+4,230
PERSPECTIVE THERAPEUTICS INC(CATX)0926,557+926,55703,8643.84%+3,864
ALUMIS INC0166,959+166,95903,6783.65%+3,678
UROGEN PHARMA LTD(URGN)0202,124+202,12403,6343.61%+3,634
PROMIS NEUROSCIENCES INC(PMN)249,339414,219+164,8801,7025,2615.23%+3,559
CAPRICOR THERAPEUTICS INC(CAPR)0113,899+113,89903,4633.44%+3,463
OVID THERAPEUTICS INC(OVID)1,785,0002,818,459+1,033,4592,9106,2576.22%+3,347
MINERVA NEUROSCIENCES INC(NERV)1,655,5001,655,50006,6559,9749.91%+3,319
SOLID BIOSCIENCES INC413,625766,974+353,3492,3335,5225.49%+3,189
INHIBIKASE THERAPEUTICS INC(IKT)01,325,000+1,325,00002,2262.21%+2,226
AN2 THERAPEUTICS INC0526,315+526,31501,8001.79%+1,800
EUPRAXIA PHARMACEUTICALS INC(EPRX)397,895660,375+262,4803,0044,7814.75%+1,777
RELMADA THERAPEUTICS INC(RLMD)0210,525+210,52501,4651.46%+1,465
WHITEHAWK THERAPEUTICS INC(WHWK)817,939817,93901,9792,8222.80%+842
EDGEWISE THERAPEUTICS INC(EWTX)195,000161,000-34,0004,8395,0725.04%+233
SOLENO THERAPEUTICS INC168,029200,000+31,9717,7806,6966.65%-1,084
TAYSHA GENE THERAPIES INC(TSHA)457,1320-457,1322,5140—-2,514
INVENTIVA SA(IVA)1,500,000745,300-754,7006,9754,1364.11%-2,839
ABIVAX SA(ABVX)70,00033,712-36,2889,4403,7543.73%-5,686
ATAI BECKLEY NV1,713,1050-1,713,1057,0070—-7,007
Page 1 of 1
Ally Bridge Group (NY) LLC — 13F Holdings — Q1 2026 | TickerTrail